Liabilities, Current in USD of Elicio Therapeutics, Inc. from Q4 2020 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Elicio Therapeutics, Inc. quarterly Liabilities, Current history and change rate from Q4 2020 to Q3 2025.
Elicio Therapeutics, Inc. Liabilities, Current for the quarter ending 30 Sep 2025 was $6.52M, a 27.8% decline year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Change (%)

Elicio Therapeutics, Inc. Quarterly Liabilities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$6.52M	-$2.51M	-27.8%	30 Sep 2025	10-Q	13 Nov 2025
Q2 2025	$9.92M	+$2.34M	+30.8%	30 Jun 2025	10-Q	07 Aug 2025
Q1 2025	$11.4M	+$5.46M	+91.8%	31 Mar 2025	10-Q	13 May 2025
Q4 2024	$11.5M	+$1.77M	+18.1%	31 Dec 2024	10-Q	13 Nov 2025
Q3 2024	$9.02M	-$2.47M	-21.5%	30 Sep 2024	10-Q	13 Nov 2024
Q2 2024	$7.59M	-$12K	-0.16%	30 Jun 2024	10-Q	13 Aug 2024
Q1 2024	$5.95M	+$3.92M	+193%	31 Mar 2024	10-Q	15 May 2024
Q4 2023	$9.76M	+$2.89M	+42%	31 Dec 2023	10-K	31 Mar 2025
Q3 2023	$11.5M	+$3.3M	+40.4%	30 Sep 2023	10-Q	13 Nov 2023
Q2 2023	$7.6M	-$183K	-2.35%	30 Jun 2023	10-Q	14 Aug 2023
Q1 2023	$2.03M	-$8.35M	-80.4%	31 Mar 2023	10-Q	10 May 2023
Q4 2022	$6.87M	-$4.43M	-39.2%	31 Dec 2022	10-K	29 Mar 2024
Q3 2022	$8.18M	-$9.76M	-54.4%	30 Sep 2022	10-Q	14 Nov 2022
Q2 2022	$7.78M	-$12.7M	-62.1%	30 Jun 2022	10-Q	15 Aug 2022
Q1 2022	$10.4M	-$6.58M	-38.8%	31 Mar 2022	10-Q	16 May 2022
Q4 2021	$11.3M	-$96.2M	-89.5%	31 Dec 2021	10-K	17 Mar 2023
Q3 2021	$17.9M			30 Sep 2021	10-Q	12 Nov 2021
Q2 2021	$20.5M			30 Jun 2021	10-Q	12 Aug 2021
Q1 2021	$17M			31 Mar 2021	10-Q	17 May 2021
Q4 2020	$107M			31 Dec 2020	10-K	30 Mar 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.